| 000 | 01581 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515072551.0 | ||
| 264 | 0 | _c20080214 | |
| 008 | 200802s 0 0 eng d | ||
| 022 | _a0423-104X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGholamrezanezhad, Ali | |
| 245 | 0 | 0 |
_a[On-levothyroxine measurement of thyroglobulin is not a reliable test for the follow-up of patients at high risk for remnant/recurrent differentiated thyroid carcinoma]. _h[electronic resource] |
| 260 |
_bEndokrynologia Polska _c |
||
| 300 |
_a100-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aCarcinoma, Papillary, Follicular _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xblood |
| 650 | 0 | 4 |
_aNeoplasm, Residual _xblood |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 |
_aThyroglobulin _xblood |
| 650 | 0 | 4 |
_aThyroid Hormones _xtherapeutic use |
| 650 | 0 | 4 |
_aThyroid Neoplasms _xblood |
| 650 | 0 | 4 | _aThyroidectomy |
| 650 | 0 | 4 |
_aThyroxine _xtherapeutic use |
| 700 | 1 | _aSaghari, Mohsen | |
| 700 | 1 | _aMirpour, Sahar | |
| 700 | 1 | _aBeiki, Davood | |
| 700 | 1 | _aTarbiat, Ali | |
| 700 | 1 | _aJavan, Shabnam | |
| 700 | 1 | _aAbdollahzadeh, Javaher | |
| 773 | 0 |
_tEndokrynologia Polska _gvol. 58 _gno. 2 _gp. 100-4 |
|
| 999 |
_c17116441 _d17116441 |
||